We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUE
6526
CALL
DELISTED
TrueCar
TRUE
$11K ﹤0.01%
+800
New +$9.79K
USL icon
6527
United States 12 Month Oil Fund,
USL
$43.3M
$11K ﹤0.01%
402
-7,800
-95% -$195K
VALU icon
6528
Value Line
VALU
$361M
$11K ﹤0.01%
429
+351
+450% +$8.28K
VONV icon
6529
Vanguard Russell 1000 Value ETF
VONV
$22B
$11K ﹤0.01%
+200
New +$11K
GFED
6530
DELISTED
Guaranty Federal Bancshares In
GFED
$11K ﹤0.01%
+461
New +$11.4K
VAR
6531
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
$11K ﹤0.01%
100
-400
-80% -$45.2K
GSUM
6532
DELISTED
Gridsum Holding Inc.
GSUM
$11K ﹤0.01%
1,711
-15,569
-90% -$95.9K
ARRY
6533
CALL
DELISTED
Array Biopharma Inc
ARRY
$11K ﹤0.01%
700
-55,800
-99% -$855K
HDP
6534
CALL
DELISTED
Hortonworks, Inc.
HDP
$11K ﹤0.01%
+500
New +$10.4K
SBNY
6535
PUT
DELISTED
Signature Bank
SBNY
$11K ﹤0.01%
+100
New +$11.8K
ZNB
6536
Zeta Network Group
ZNB
$2.4M
0
AIR icon
6537
CALL
AAR Corp
AIR
$5.76B
$10K ﹤0.01%
200
-800
-80% -$36.8K
CHI
6538
Calamos Convertible Opportunities and Income Fund
CHI
$1.05B
$10K ﹤0.01%
800
CNDT icon
6539
PUT
Conduent
CNDT
$264M
$10K ﹤0.01%
460
DHX icon
6540
DHI Group
DHX
$173M
$10K ﹤0.01%
5,051
-57,529
-92% -$121K
DOG
6541
ProShares Short Dow30
DOG
$86.8M
$10K ﹤0.01%
190
+186
+4,650% +$10.6K
EEFT icon
6542
CALL
Euronet Worldwide
EEFT
$2.7B
$10K ﹤0.01%
100
FHN icon
6543
CALL
First Horizon
FHN
$12.1B
$10K ﹤0.01%
600
IEUS icon
6544
iShares MSCI Europe Small-Cap ETF
IEUS
$185M
$10K ﹤0.01%
177
IYF icon
6545
iShares US Financials ETF
IYF
$4.39B
$10K ﹤0.01%
166
-1,200
-88% -$73.5K
PPLT
6546
abrdn Physical Platinum Shares ETF
PPLT
$2.04B
$10K ﹤0.01%
1,310
PXJ icon
6547
Invesco Oil & Gas Services ETF
PXJ
$61.3M
$10K ﹤0.01%
200
TACT icon
6548
Transact Technologies
TACT
$58.6M
$10K ﹤0.01%
710
-1
-0.1% -$13
ERF
6549
PUT
DELISTED
Enerplus Corporation
ERF
$10K ﹤0.01%
800
-1,500
-65% -$18.9K
SALM
6550
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$10K ﹤0.01%
+2,796
New +$12.2K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.